Navigation Links
Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
Date:5/7/2009

NEW YORK, May 7 /PRNewswire-FirstCall/ -- Delcath Systems, Inc., (Nasdaq: DCTH) a medical technology company testing its proprietary Percutaneous Hepatic Perfusion (PHP(TM)) System for the treatment of cancers of the liver, announced today that Eric D. Whitman, MD, Director of the Atlantic Melanoma Center and a Principal Investigator of Delcath's Phase III trial, will present at The 7th World Congress on Melanoma, to be held in Vienna, Austria, May 12-16, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO )

Dr. Whitman's presentation, titled Percutaneous Isolated Hepatic Perfusion for Cutaneous and Uveal Metastatic Melanoma, will discuss his experience with the Delcath PHP System(TM), as part of Delcath's multi-center Phase III trial for metastatic melanoma, currently enrolling at twelve leading cancer centers throughout the United States.

This clinical study is testing the Delcath PHP System(TM) for the regional delivery of melphalan to the liver to treat patients with metastatic cutaneous and ocular melanoma who have unresectable tumors in the liver. The Delcath PHP System(TM) is designed to deliver significantly higher doses of anti-cancer drugs to a patient's liver while minimizing entry of the drugs into the rest of the patient's circulation. This isolation limits toxicities which result from systemic chemotherapy treatments.

Patients in the Phase III trial are randomized into one of two treatment arms, including immediate treatment with melphalan via the Delcath PHP System(TM) or treatment with best alternative care. The study is designed to evaluate the duration of tumor
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Avicena Group to Present at Noble Financial Conference
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CEL-SCI to Present at the Noble Financial Conference
7. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
8. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
9. Strategic Diagnostics Updates Roth Conference Presentation Time
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
(Date:6/18/2013)... Canada (PRWEB) June 18, 2013 ... oversight of pharmaceutical advertising and promotion, and review ... Viewers will learn how to apply these principles ... examples:, ,     The fundamentals on FDA ... and promotional labeling ,     Assessing traditional and ...
(Date:6/18/2013)... 2013 Research and ... addition of the "Injectable Drug Delivery ... Devices [Disposables & Reusable, Fillable & Prefilled, ... Therapeutics [Diabetes & Oncology] - Global Forecasts ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ...
(Date:6/18/2013)... As a leading provider of telehealth ... release of their infographic - " 8 New ... goal was to leverage an information graphic to ... 3.0 and mHealth.The infographic features a list of ... the fitness industry in unimaginable ways; turning science ...
Breaking Biology Technology:Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
... Jan. 23 PPD, Inc. (Nasdaq:,PPDI) today announced ... services,into China through an exclusive agreement with Peking ... PPD to begin,immediately providing biopharmaceutical clients with its ... China., "Chinese law makes it extremely difficult ...
... 23 /PRNewswire/ - Dalton Medicinal Chemistry Partners,the ... announces that it,has achieved another targeted milestone ... (Canada) Ltd., Dalton Medicinal Chemistry Partners ... and synthesize novel compounds against an,antiviral target ...
... modeled after biological olfaction, the challenge has been to ... combinatorial complexity to detect odors in the real world. ... manufactured with exact chemical precision and reproducibility. , In ... journal PLoS Biology, Joel White, Mary AtKisson, John Kauer ...
Cached Biology Technology:PPD Expands Global Central Lab Services into China 2PPD Expands Global Central Lab Services into China 3
(Date:6/18/2013)... 18, 2013 The herbal extract of a yellow-flowered ... to increase the lifespan of fruit fly populations by ... researchers. , But it,s how Rhodiola ... that grabbed the attention of study leaders Mahtab Jafari ... works in a manner completely unrelated to dietary restriction ...
(Date:6/18/2013)... June 2013). A team of internationally recognized feline experts ... Ellis from the University of Lincoln, U.K. and Dr ... were invited by the International Society of Feline Medicine ... to compile guidelines for veterinarians, owners and those working ... of the domestic cat. The new guidelines appear in ...
(Date:6/17/2013)... locations with central nervous system infections may well be ... according to a study to be published in ... Society for Microbiology. Researchers have detected the virus in ... central nervous system infections of unknown cause, and in ... pigs and poultry, suggesting animals may serve as reservoirs ...
Breaking Biology News(10 mins):Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2Feline behavior experts release guidelines to improve the welfare of cats 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... RIDGE, Tenn, April 8, 2011 -- A newly sequenced ... of Energy,s Oak Ridge National Laboratory could contain clues ... of mercury. Methylmercury, a potent human neurotoxin, ... transform inorganic mercury into its more toxic cousin. Few ...
... Neurosurgeons from NYU Langone Medical Center will present techniques ... the annual meeting of the American Association of Neurological ... Convention Center in Denver. The Department of ... as one of the top ten hospitals in the ...
... ST. LOUIS Saint Louis University researchers have identified ... fluid from tissues to lymphatic vessels. It may be possible ... organ to another organ and improve the effectiveness of vaccines. ... consisting of vessels in the body. It defends the body ...
Cached Biology News:Bacterial genome may hold answers to mercury mystery 2NYU Langone experts present advances at American Association of Neurological Surgeons Meeting 2Outsmarting cancer cells: SLU scientists learn how they spread 2
Rad51, N-terminal...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Biology Products: